Pune, India, April 10, 2019 (GLOBE NEWSWIRE) -- Global 3D bioprinting market is presumed to touch a valuation of USD 1,923.02 million during the forecast period (2018-2023), Market Research Future unveils in a detailed analysis. The market is expected to generate an impressive CAGR of 24.59% in the long run. Encompassing an array of 3D printing methods, 3D bioprinting combines biomaterials and cells for the production of biomedical parts. Termed as additive manufacturing, 3D printing has harbored numerous innovations in several areas of manufacturing, medicine, education, and engineering. The increased burden of chronic diseases is presumed to dictate the growth trajectory of the market.

Prominent Players

Presently, some market players are contributing to the 3D bioprinting market growth. Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Poietis (France), Organovo Holdings Inc. (U.S.), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), EnvisionTEC GmbH (Germany), Stratasys Ltd. (U.S.), Cellink AB (Sweden), REGENHU Ltd. (Switzerland), Cyfuse Biomedical K.K. (Japan), and Aspect Biosystems Ltd. (Canada) are among them.

Industry Upgradations

April 04, 2019: Biogelx has recently declared the launch and the commercial availability of the first synthetic bio-ink product range. Biogelx-INKs can form a nanofibrous network, by mimicking the extracellular matrix which can further support the growth of the cell. They have been developed in order to ensure the rheological properties are suitable for bioprinting applications.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/869

Demand for Organ Transplantation Encouraging the Market Growth

Organ transplantation is one of the key factors highly influencing the 3D bioprinting market across the globe. The process of using bio-ink composed of human cells and tissues, 3D bioprinting has evolved over the years. The aim of developing function organs like ears, kidneys, and livers is gradually becoming a reality. A 3D printed replica kidney from axial3D, a UK-based 3D printed medical model company has facilitated a vital, crucial transplant operation, thereby improving the life of the organ donor. The increased prevalence of chronic diseases which demands tissue and organ transplant has ensured a burgeoning market for 3D bioprinting.

3D bioprinting is cost-economical which has further triggered its demand across the globe. There have been notable investments in 3D bioprinting through private and public means which has enabled the market to reach out to a wider range of audiences. For instance, the Finnish Funding Agency for Innovation, Tekes awarded funds to the University of East Finland in order to develop a fully functioning 3D brain which was to be used for research purposes. Several startup companies such as Cyfuse Biomedical and Nano 3D Bioscience have entered the market to open up new avenues for the market to expand. Prominent players are gaining entry in the global market by acquiring startups, which is further encouraging 3D bioprinting market growth.

Meanwhile, the dearth of skilled professionals and lack of awareness regarding the technology are some of the top barriers highly vitiating the market growth across the globe. The equipment used for bioprinting is still unaffordable in some of the emerging nations. This is likely to slow down the market growth in the long run.

Segmental Analysis

Laser-assisted bioprinting, inkjet 3D bioprinting, magnetic 3D bioprinting, and micro-extrusion bioprinting forms the technology-based segmentation of the global 3D bioprinting market. Micro extrusion bioprinting is extensively used by the researchers as a mode of an alternative to scaffold fabrication. The segment’s growth can be ascribed to the high cell densities due to the use of bio-inks in order to mimic matrices. The inkjet 3D bioprinting is predicted to occupy a significant share due to its high compatibility with the living cells.

The material segment comprises living cells, extracellular matrices, hydrogels, and others. Living cells command a major share due to its manufacture using in-air microfluidics. They play a major role in repairing damaged tissues. Moreover, the compatibility of living cells with biomaterials to form damaged microstructures is estimated to intensify the segment’s growth. Due to the manufacturer using natural and synthetic materials, the demand for hydrogels is relatively high in the 3D Bioprinting Market.

By application, the market constitutes of clinical and research applications. Among these, the segment for clinical applications is estimated to command a high demand due to organ transplantation. The shortage of organs has created ample scope for the market to expand. Due to the emerging field of regenerative medicine, the segment for research application is also estimated to occupy a significant spot.

The 3D Bioprinting market has been segmented into pharmaceutical and biotechnology companies and research organizations & academic institutes as per end-users. Pharmaceutical & biotechnology companies are highly dependent on technology to cater to the demands of the patients. With the emergence of personalized medicines, the segment can generate revenue for the market.

Browse the market data and information spread across 163 pages with 176 data tables and 21 figures of the report “3D Bioprinting Market- Forecast 2018-2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869

Regional Frontiers

The regions discussed in the report spans across Europe, America, Asia Pacific, and the Middle East & Africa. Due to the constant development of the healthcare sector, a noticeable growth in the R&D activities, the rising budget for healthcare in Canada and the U.S., and the presence of a large patient population, America is likely to secure the top position. The development of 3D pills which can be customized as per the person’s body weight and age has created growth opportunities for the 3D Bioprinting market in this region.

The constant development in the healthcare sector, the presence of huge opportunities, and development in 3D printing has ensured the region to expand at a rapid pace. The APAC region is presumed to garner USD 507.18 million, grabbing a CAGR of 27.25% by the end of 2023. Funding from the government in order to accelerate the pace of printing technology has triggered its demand.

The European region is touted to touch a valuation of USD 649.91 million by the end of the appraisal period. Increased focus on health and wellness along with the increased demand for cosmetic surgery are creating huge opportunities for the 3D Bioprinting market in this region.

Browse Related Reports:

3D Cell Culture Market by Technique (Scaffolds Based 3D Cell Culture, Scaffold-Free 3D Cell Culture), Product (Consumables), by Application (Cancer Research), and End-User (Pharmaceutical & Biotechnology Companies) - Global Forecast till 2023
https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928

3D Printing Medical Devices Market by Types (Surgical Guides), Component (System and others), Technology (3D printing and others), by Application (External Wearable Devices, Implants), and End-Users - Forecast till 2023
https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com